The Latest Breaking News on Pharma

A Twitter imposter cost a US pharmaceutical giant billions of dollars, but the viral prank triggered another unexpected crisis -- a new wave of scrutiny of the high cost of its insulin. Authentic-looking fake accounts proliferated last week after Twitter rolled out a paid verification service, the latest in a…

ATAGI gave the new Pfizer jab the all-clear on Tuesday.

A hybrid "Deltacron" strain could overtake BQ.1.1 as the most prevalent COVID strain. Here's what that would mean

Psychedelics biopharma company Reunion Neuroscience Inc. (NASDAQ: REUN) reported its business update and fiscal results for the second quarter ended September 30, 2022.

If India is the pharmacy of the world, it’s not doing a good job of providing safe products. A large number of children in the Gambia have recently died after ingesting cough syrup made in India. And in 2019, 11 children in India’s Jammu region died the same way. The…

Gilead Sciences’ (GILD) popular covid product Veklury (Remdisivir) witnessed declining sales in the post-pandemic era. However, the company’s top line, excluding Veklury, has seen steady growth. Moreover, despite ongoing market volatility, the stock has registered stable gains. So, let’s find out if GILD is still a buy in the post-covid…

It was one of the first CBD companies in the UK almost 10 years ago

U.S. stocks traded mixed, with the Nasdaq gaining more than 50 points on Monday. Here are some big stocks recording losses in today’s session.

Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), released financial results for the third quarter ended September 30, 2022. Q3 2022 Financial Highlights